Phoenixville, PA, United States of America

Thomas R Bailey

USPTO Granted Patents = 54 (Patent Applications = 6)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 4.0

ph-index = 11

Forward Citations = 547(Granted Patents)

Forward Citations (Not Self Cited) = 495(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Bethlehem, NY (US) (1990 - 1992)
Town of Bethlehem, NY (US) (1992)
Phoeniville, PA (US) (2008)
Pheonixville, PA (US) (2010)
Phoenixville, PA (US) (1995 - 2023)

Company Filing History:

13 out of 57

Siga Technologies Inc.

patents

12 out of 23

Viropharma Incorporated

patents

7 out of 206

Sterling Winthrop Inc.

Sophrosyne Pharmaceuticals Limited

patents

10. 1 out of 5

Sanofi Pharmaceuticals, Inc.

The Children's Hospital of Philadelphia

where one patent can have more than one assignee

Years Active: 1990-2024

Loading Chart...

54 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12171753 - Crystalline forms of ALDH2 modulators (2024-12-24),

2. 11649208 - Compounds and methods for treating alcohol disorder (2023-05-16),

3. 11608324 - Solid forms of fasoracetam (2023-03-21),

4. 9115065 - Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with Arenaviruses (2015-08-25),

5. 9067873 - Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses (2015-06-30),

6. 9045418 - [object Object] (2015-06-02),

7. 8802714 - Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases (2014-08-12),

8. 8765779 - Tricyclic derivatives and their pharmaceutical use and compositions (2014-07-01),

9. 8673916 - [object Object] (2014-03-18),

10. 8664274 - Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses (2014-03-04),

11. 8658697 - Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses (2014-02-25),

12. 8648067 - [object Object] (2014-02-11),

13. 8642596 - Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses (2014-02-04),

14. 8586588 - Aryl pyridazinone derivatives and their use as H3 receptor ligands (2013-11-19),

15. 8530509 - Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases (2013-09-10),

Title:

Inventor Spotlight: Thomas R Bailey - Paving the Way for Innovative Medical Treatments

Introduction:

Meet Thomas R Bailey, a prolific inventor based in Phoenixville, PA, with an impressive portfolio of 53 patents to his name. Bailey's groundbreaking work in the field of pharmaceuticals is revolutionizing the treatment of alcohol-related disorders and cognitive health.

Latest Patents:

Bailey's latest patents showcase his commitment to addressing critical health issues. One notable patent is for "Compounds and methods for treating alcohol disorder," which focuses on developing compounds to modulate the activity of aldehyde dehydrogenase for the treatment and prevention of alcohol-related disorders. Another patent highlights "Solid forms of fasoracetam," introducing innovative cocrystals of fasoracetam for enhanced pharmaceutical compositions and treatments.

Career Highlights:

Throughout his career, Bailey has made significant contributions to companies at the forefront of medical innovation. He has lent his expertise to Siga Technologies Inc. and Viropharma Incorporated, where his research and inventions have propelled advancements in drug development and patient care.

Collaborations:

Bailey's collaborative spirit is evident through his partnerships with esteemed colleagues such as Guy D Diana and Theodore John Nitz. Together, they have worked tirelessly to bring cutting-edge solutions to the pharmaceutical industry, impacting the lives of countless individuals worldwide.

Conclusion:

In conclusion, Thomas R Bailey's dedication to scientific excellence and commitment to improving healthcare outcomes make him a pioneering figure in the world of medical inventions. His relentless pursuit of innovative solutions underscores the profound impact inventors can have on shaping a healthier future for society.

This text is generated by artificial intelligence and may not be accurate.